Metraipolis › archive › dc_bdcbdfd610a4

Multimodal PA/US imaging and radiomics for the prediction of HER2-zero, -low, and -positive breast cancers: A novel approach for targeted therapy selection — Europe PMC PMID:40979269

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40979269
DOI: 10.1016/j.pacs.2025.100764
License (as archived): solo-consultazione
Archived: 2026-11-10T11:40:12.987Z
SHA-256 of the archived text: 4d1ed96381c552c4f5707e03fc27800bfcc9a001f93eb37328d5f4af7cf1f01c
Stable URL of this page: https://metraipolis.com/documento/dc_bdcbdfd610a4

How to cite

Multimodal PA/US imaging and radiomics for the prediction of HER2-zero, -low, and -positive breast cancers: A novel approach for targeted therapy selection — Europe PMC PMID:40979269 — Europe PMC (en), https://europepmc.org/article/MED/40979269 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bdcbdfd610a4 (Metraipolis archive dc_bdcbdfd610a4, sha256 4d1ed96381c552c4f5707e03fc27800bfcc9a001f93eb37328d5f4af7cf1f01c)

BibTeX

@misc{dcbdcbdfd610a4,
  title = {Multimodal PA/US imaging and radiomics for the prediction of HER2-zero, -low, and -positive breast cancers: A novel approach for targeted therapy selection — Europe PMC PMID:40979269},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40979269},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bdcbdfd610a4; sha256 4d1ed96381c552c4f5707e03fc27800bfcc9a001f93eb37328d5f4af7cf1f01c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40979269. Agents can read the archived copy with the MCP tool read_document.